Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

A QMS is the organization’s system for managing quality; an eQMS is software used to carry out or document parts of that system. The terms “eQMS” and “QMS software” are often used for the same kind of tool, but neither describes the quality system itself. Buying software does not create a compliant QMS, and being a digital health company does not by itself make a business subject to one particular regulation. The right approach depends on what the company makes, what it does, and which regulatory or certification requirements apply.

What is the difference between eQMS and QMS software?

A quality management system, or QMS, is the framework of processes, responsibilities, and records an organization uses to manage quality. It includes decisions about how work is performed, who is accountable, how problems are handled, and what evidence is retained.

An electronic QMS, or eQMS, is software that helps manage some of those activities and records. “QMS software” is a broader, commonly used label for software serving that purpose. In practice, the labels often overlap; the important distinction is between the organization’s quality system and a tool used to support it.

Term What it refers to What it does not establish
QMS The organization’s quality processes, assigned responsibilities, and controlled records. It is not necessarily a software product or a particular vendor’s platform.
eQMS / QMS software A software tool used to execute, organize, or document parts of a QMS. Its purchase alone does not establish that the company has implemented an adequate or compliant QMS.

Software can make records and workflows easier to manage, but the organization still needs appropriate procedures, trained people, defined responsibilities, and evidence that its processes work for their intended use.

Free tools Windows power users keep installed

One-click scans. No signup required.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.
#1 Best Overall

Does a digital health company need an eQMS?

Not every digital health company faces the same quality-system rules, and a software purchase should not be the first step in deciding that question. “Digital health” can describe a medical-device manufacturer, a developer of software that is itself a medical device, a clinical software vendor, or a health IT developer pursuing certification. The applicable obligations depend on the product, the company’s role, its activities, and the regulatory or certification pathway.

Company context What to establish first
Finished medical-device manufacturer intending commercial distribution in the United States Determine how FDA’s QMSR applies to the organization and its products. FDA says the rule applies to finished device manufacturers intending commercial distribution, including certain accessories considered finished devices. [FDA QMSR overview]
Medical-device software or software-as-a-medical-device developer Establish the product’s regulatory status and the company’s role before deciding which quality-system obligations apply. Do not assume every health app or software product is a regulated medical device.
Health IT developer pursuing applicable ONC certification Identify the QMS relevant to the certification criteria and map it to recognized QMSes as required in that certification context. This is not a blanket rule for every digital health company. [ONC quality management system test method]
Company conducting clinical investigations Assess requirements for the clinical-research systems and records used by sponsors, investigators, IRBs, CROs, and other participants. FDA’s clinical-investigation electronic-systems guidance is specific to that context, not a general eQMS purchasing rule.

This distinction matters for startups as much as established firms: a company may need a documented quality approach before it needs a dedicated platform, while a company with applicable regulatory obligations cannot substitute a platform for understanding and implementing those obligations.

What does FDA’s QMSR mean for medical-device companies?

FDA’s Quality Management System Regulation (QMSR) became effective on February 2, 2026. It amends 21 CFR Part 820 and incorporates ISO 13485:2016 by reference; it did not simply replace Part 820 with ISO 13485. The FD&C Act and implementing regulations control if a conflict arises. [FDA QMSR overview]

Rank #2
Quality Software Management: Anticipating Change
  • Quality Software Management: Anticipating Change Volume 4
  • By Gerald M. Weinberg
  • 9780932633323

For firms already operating a quality system, the effective date does not make earlier records irrelevant. FDA says investigators conducting QMSR inspections on or after February 2, 2026, may review QMS records created before that date. FDA may also inspect management review, quality audit, and supplier audit reports; the former exception for those reports under the QS regulation is not maintained. A comparative analysis can help a firm explain how pre-effective-date records meet QMSR requirements. FDA began using updated inspection program 7382.850 on the effective date. [FDA QMSR frequently asked questions]

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

For a company selecting or changing software, this makes historical-record handling part of the decision: consider how existing records will be retained, retrieved, traced, and explained alongside records created under current procedures.

What should you look for in QMS software?

Start with the quality processes the organization actually needs to manage, then evaluate candidate tools against the requirements and risks of those processes. The following are decision criteria, not a guarantee that any particular product supports them:

  • Scope and obligations: Identify the applicable regulatory or certification requirements and the parts of the QMS the software is expected to support.
  • Workflow coverage: Map needed processes, which may include document control, training, nonconformance, corrective and preventive action (CAPA), complaints, supplier controls, change control, and design and development records.
  • Intended use and risk: Define what each workflow and record is used for, and how failures could affect product quality, safety, or record integrity.
  • Record controls: Assess access controls, review and approval history, electronic signatures where applicable, retention, export, and traceability.
  • Configuration and integrations: Account for connections to design, issue-tracking, clinical, manufacturing, or ERP systems, including how changes and data flows will be controlled.
  • Usability: Check whether the actual employees and relevant suppliers can follow the workflows consistently, rather than evaluating features only in a demonstration.
  • Migration and implementation: Plan how current documents and records will move, how procedures will change, and what training and evidence are needed.
  • Ongoing ownership: Confirm the organization can sustain the procedures, user training, system oversight, and records after deployment.

A feature list is not a substitute for this mapping. A system can offer many controls yet still be unsuitable if its configuration, integrations, or intended use do not support the company’s actual processes.

How should a company implement QMS software?

  1. Define scope. Document the products, activities, regulatory or certification contexts, and quality processes the system is intended to support. Resolve uncertainties about regulatory status before treating a platform choice as a compliance decision.
  2. Map current and required workflows. Identify process owners, inputs, approvals, outputs, records, and handoffs. Include systems that will exchange data with the proposed software.
  3. Assess gaps and risk. Compare existing practices with applicable requirements and determine where a software tool could reduce manual effort or improve control. Set priorities based on the impact of process or record failures.
  4. Evaluate and configure against intended use. Test realistic workflows, roles, permissions, integrations, and records. Document why the configuration is appropriate for the organization’s use.
  5. Train users and establish procedures. Explain how work is performed in the system, who reviews or approves records, and how exceptions and changes are handled.
  6. Maintain the system and its evidence. Keep procedures, training, configuration decisions, and relevant records current as the product, organization, software, or applicable requirements change.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Support on Ko-Fi

How do FDA software assurance and validation apply?

FDA’s February 2026 Computer Software Assurance guidance covers software used as part of medical-device production or the quality management system. It recommends a risk-based approach to establish confidence in software, determine where additional rigor is appropriate, and select testing activities. The February 2026 guidance supersedes FDA’s September 24, 2025 final guidance. [FDA Computer Software Assurance guidance]

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

That makes assurance a company-specific activity, not simply a document supplied by a vendor. A vendor’s validation package may be useful evidence, but it does not by itself show that the customer’s intended use, configuration, integrations, and procedures are adequately assured. The organization must assess its own context and the risks of the software’s use.

ISO/TR 80002-2:2017 is a published technical report on validation of software for medical-device quality systems. ISO describes its scope as software used in a QMS, production and service provision, and monitoring and measurement; it excludes software that is itself a medical device. It can inform a software-validation approach, but buying a standard or guide does not replace implementation of the company’s own quality system.

Do Part 11 controls apply to every electronic QMS record?

No. FDA’s Part 11 Scope and Application guidance describes a narrow interpretation of scope and recommends a documented risk assessment that considers predicate-rule obligations and potential effects on product quality, safety, and record integrity. Part 11 remains in effect, and this approach does not remove independent requirements that apply under predicate rules. [FDA Part 11 Scope and Application guidance]

FDA recommends basing the approach on a justified, documented assessment of the system’s potential to affect product quality and safety and record integrity. Its guidance also describes enforcement discretion for specified Part 11 audit-trail provisions while retaining applicable predicate-rule requirements and recommending risk-based decisions. Do not assume that every digital record requires identical controls—or that an electronic QMS makes electronic records exempt from applicable obligations.

Special offer. See more information about Outbyte and uninstall instructions. Please review EULA and Privacy policy.

Quick Recap

Bestseller No. 1
Bestseller No. 2
Quality Software Management: Anticipating Change
Quality Software Management: Anticipating Change
Quality Software Management: Anticipating Change Volume 4; By Gerald M. Weinberg; 9780932633323
$12.02
Bestseller No. 4

Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.